ACAD Archived Articles

Acadia Pharmaceuticals Inc. (ACAD): Executing on a Promising Neuroscience Pipeline


ACADIA Pharmaceuticals (NASDAQ:ACAD) Poised for Continued Growth with Robust Commercial Franchises and Promising Pipeline